Oxford Technology Management is an Oxford, England based venture capital firm. They invest in start-up and early stage technology-based businesses with the prospect of growth. They were founded in 1983 by Lucius Cary.
Oxford Technology Management manages two funds, the Start-up Fund through which they invest in science start-ups. The fund is open for investment and invests between £15,000 to £320,000 to any company in their first, second or third year showing promise.
Oxford Technology Management's second fund is their Development Fund, which develops in high growth potential, technology-based companies, typically used to employ more people, expand sales force and increase marketing expenditure and is often lower risk than the Start-up Fund.
Oxford Technology Management has made investments in Atelerix, Lightpoint Medical, Bodle Technologies, Gripable, Ducentis BioTherapeutics, Glide Pharmaceutical Therapeutics, OxSonics, Electrowinning Technologies, Curileum Discovery, Lupe Technology and ActiveNeedle.
They have exited their investments in Mirriad, Scancell, Agilent Raman Spectroscopy, Acunu, OC Robotics, Commerce Decisions, Hardide Coatings, Dexela, Impact Applications, Telegesis, BioAnaLab, Equitalk, Membrane Extraction Technology, Warwick Effect Polymers and Valid Information Systems.
Founder and Managing Director